Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs


Mark Lowcock speaking at a CGD event

Mark Lowcock Will Bring Development Finance, Humanitarian Assistance Expertise to CGD

We are thrilled to announce that Mark Lowcock will join CGD as distinguished non-resident fellow, effective tomorrow, June 20, 2021. He will contribute his wide-ranging expertise and wisdom to many facets of CGD’s work, but his initial focus on our Sustainable Development Finance and Migration, Displacement and Humanitarian Policy programs. We are very much looking forward to publishing his book [on accountability in the global humanitarian system, expected in Spring 2022].

An overhead show of Dhaka, Bangladesh

Bangladesh: Growth Miracle or Mirage?

Among South Asian economies, Bangladesh is touted as a rising star.  But is the praise entirely justified? Can Bangladesh now serve as a model for other countries, perhaps offering an alternative to the longstanding East Asian export-led growth paradigm? The jury is still out however, and the evidence raises doubt that the East Asian icons face serious competition from Bangladesh—at least not yet.

An image of a woman in India receiving the COVID vaccine.

Can SMS-based Information Campaigns Help Prevent the Spread of COVID-19 in India?

Preventive behaviors such as handwashing and social distancing are critical to containing the spread of infectious diseases like COVID-19, particularly in densely populated areas of low-income countries with crowded living quarters and public spaces. But it can be challenging to identify and deploy effective interventions to encourage widespread knowledge and adoption of these behaviors.

Image of a syringe and a bottle of vaccine

What’s the Right Price for Surplus COVID-19 Vaccines? The Answer Is Closer to Zero Than You Might Think.

Many rich countries pre-ordered vast quantities of COVID-19 vaccines when they were still in development, enough to vaccinate their countries many times over.  What is the right ‘price’ to pay for surplus vaccines, as opposed to those newly purchased? And how much of their value should be counted as Official Development Assistance (ODA)? The choice matters for two reasons: firstly, it sets a precedent for the valuation of secondhand goods as development aid, which in turn sets incentives for donors. And secondly, some donors operate an ODA ceiling